ARCHIVES

In Brief: FDA To Review Preclinical Testing, Phase I Protocols At Open Advisory Group Meeting

This article is from The Cancer Letter archive.

Vol. 01 No. 46 | November 14, 1975

Download PDF Visit The Full Archive

Related Articles

Guest Editorial: The Academic Difference: George Weiner On How America’s Cancer Centers Are More Valuable Than Ever

October 31, 2014

MUSC Hollings Cancer Center awarded NCI designation

February 1, 2021

Senate Approves Appropriations Bill; GRH Threatens It

October 23, 1987

In Brief: Wyngaarden Suspends NIH Funds for Pennsylvania Head Injury Center Over Animal Care Problems

July 26, 1985

In Brief: Hammond Honored By ACS; SEER Celebrates 20th Anniversary With Symposium Dec. 8

December 3, 1993

ASCO And ESMO Publish Training Recommendations

November 26, 2004